Skip to main content

Mylan launches generic Axert

11/17/2015

PITTSBURGH — Mylan on Tuesday announced that it had launched it generic version of Axert (almotriptan) tablets. The drug is indicated for acute migraine treatment in adults and acute migraines lasting more than four hours when untreated in adolescents aged 12 to 17.


The tablets will be available in 6.25- and 12.5-mg dosage strengths. The drug had U.S. sales of $29.2 million for the 12 months ended June 30. 


X
This ad will auto-close in 10 seconds